Napwa welcomes ARV factory

2012-04-02 12:48

The National Association of People Living with Aids and HIV (Napwa) in Limpopo has welcomed moves by two international pharmaceutical companies to make antiretroviral (ARV) drugs more affordable.

Hundreds of lives of people infected with HIV could be saved by the availability of “cheaper but still effective anti-Aids drugs” in South Africa, Napwa’s Limpopo secretary Lawrence Sengwane said.

“Now we hear that the factory supplying those cheaper drugs will open in Mamelodi, in Pretoria in the Gauteng province, and we just hope even here in Limpopo the government will do something for us to reach those life-saving drugs,” he said.

“Our position in Napwa has always been that we welcome any affordable anti-Aids drugs for as long as they have been approved by government.”

Limpopo health department spokesperson Joe Maila said today that he was not sure whether the ARV factory in Mamelodi would benefit Limpopo.

He said the department had set aside R268 000 this financial year to buy ARVs and R80 000 for the national health laboratory services.

“We have 493 ARV sites in the province of which seven are private. And at the end of December last year, the centres were taking care of 131 954 patients.

“Our aim is to improve access to care, reduce morbidity and mortality rate related to HIV and improve life expectancy,” Maila said.

SANOFI has reportedly joined hands with Hetero of India to manufacture affordable ARV drugs at the site to be opened in Mamelodi.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.